Cargando…
Parotid metastases from primary lung cancer: Case series and systematic review of the features
Most parotid metastases have been reported to come from the head and neck; however, cases metastasized from the lung are extremely rare. Missed diagnoses and misdiagnoses occurred quite a few times. Thus, accurately identifying the clinical features of parotid metastasis of lung cancer is important....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453833/ https://www.ncbi.nlm.nih.gov/pubmed/36091176 http://dx.doi.org/10.3389/fonc.2022.963094 |
_version_ | 1784785227432853504 |
---|---|
author | Wang, Rulan Wang, Ting Zhou, Qinghua |
author_facet | Wang, Rulan Wang, Ting Zhou, Qinghua |
author_sort | Wang, Rulan |
collection | PubMed |
description | Most parotid metastases have been reported to come from the head and neck; however, cases metastasized from the lung are extremely rare. Missed diagnoses and misdiagnoses occurred quite a few times. Thus, accurately identifying the clinical features of parotid metastasis of lung cancer is important. However, current studies about this issue are mostly case reports, and little is known about the detailed and systematic aspects. We reported three cases of parotid metastases from lung cancer and then systematically searched similar cases through “Pub-Med” and “Web of Science”. Finally, twenty-three patients were included in the study. Eighty-three percent of which were males, and 19 patients were over 50 years old. In all cases with smoking history mentioned, 93% were smokers. The predominant pathological type was small cell lung cancer (SCLC, 13 patients, 56%). Seventeen combined with other site metastasis, while more than half of which were brain metastases. The survival time ranged from 3months-17years, and as for SCLCs, it was only 3months-40months. It can be concluded that clinical features, such as sex, age, smoking history, pathological types, and metastasis patterns, could provide valuable evidence for diagnosis. The lung seems to be the most common primary site of parotid metastases except for head and neck tumors. The two circumstances, SCLC coexisting with Warthin’s tumor and parotid small cell carcinoma with lung metastasis, should be differentiated from parotid metastasis of lung cancer with caution For cases presented as SCLC, more aggressive strategies, such as chemotherapy with immunotherapy and maintenance therapy, may be more suitable. Due to the greater tendency of brain metastasis in such diseases, whole-brain radiation therapy, stereotactic radiosurgery or prophylactic cranial irradiation should be applied to corresponding patients in time. Additionally, lung cancer parotid metastases may be a marker of poor prognosis. |
format | Online Article Text |
id | pubmed-9453833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94538332022-09-09 Parotid metastases from primary lung cancer: Case series and systematic review of the features Wang, Rulan Wang, Ting Zhou, Qinghua Front Oncol Oncology Most parotid metastases have been reported to come from the head and neck; however, cases metastasized from the lung are extremely rare. Missed diagnoses and misdiagnoses occurred quite a few times. Thus, accurately identifying the clinical features of parotid metastasis of lung cancer is important. However, current studies about this issue are mostly case reports, and little is known about the detailed and systematic aspects. We reported three cases of parotid metastases from lung cancer and then systematically searched similar cases through “Pub-Med” and “Web of Science”. Finally, twenty-three patients were included in the study. Eighty-three percent of which were males, and 19 patients were over 50 years old. In all cases with smoking history mentioned, 93% were smokers. The predominant pathological type was small cell lung cancer (SCLC, 13 patients, 56%). Seventeen combined with other site metastasis, while more than half of which were brain metastases. The survival time ranged from 3months-17years, and as for SCLCs, it was only 3months-40months. It can be concluded that clinical features, such as sex, age, smoking history, pathological types, and metastasis patterns, could provide valuable evidence for diagnosis. The lung seems to be the most common primary site of parotid metastases except for head and neck tumors. The two circumstances, SCLC coexisting with Warthin’s tumor and parotid small cell carcinoma with lung metastasis, should be differentiated from parotid metastasis of lung cancer with caution For cases presented as SCLC, more aggressive strategies, such as chemotherapy with immunotherapy and maintenance therapy, may be more suitable. Due to the greater tendency of brain metastasis in such diseases, whole-brain radiation therapy, stereotactic radiosurgery or prophylactic cranial irradiation should be applied to corresponding patients in time. Additionally, lung cancer parotid metastases may be a marker of poor prognosis. Frontiers Media S.A. 2022-08-25 /pmc/articles/PMC9453833/ /pubmed/36091176 http://dx.doi.org/10.3389/fonc.2022.963094 Text en Copyright © 2022 Wang, Wang and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Wang, Rulan Wang, Ting Zhou, Qinghua Parotid metastases from primary lung cancer: Case series and systematic review of the features |
title | Parotid metastases from primary lung cancer: Case series and systematic review of the features |
title_full | Parotid metastases from primary lung cancer: Case series and systematic review of the features |
title_fullStr | Parotid metastases from primary lung cancer: Case series and systematic review of the features |
title_full_unstemmed | Parotid metastases from primary lung cancer: Case series and systematic review of the features |
title_short | Parotid metastases from primary lung cancer: Case series and systematic review of the features |
title_sort | parotid metastases from primary lung cancer: case series and systematic review of the features |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453833/ https://www.ncbi.nlm.nih.gov/pubmed/36091176 http://dx.doi.org/10.3389/fonc.2022.963094 |
work_keys_str_mv | AT wangrulan parotidmetastasesfromprimarylungcancercaseseriesandsystematicreviewofthefeatures AT wangting parotidmetastasesfromprimarylungcancercaseseriesandsystematicreviewofthefeatures AT zhouqinghua parotidmetastasesfromprimarylungcancercaseseriesandsystematicreviewofthefeatures |